{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:19:55Z","timestamp":1791987595813,"version":"4.4.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Cancer Grand Challenges"},{"name":"National Cancer Institute and Cancer Research","award":["OT2CA278691"],"award-info":[{"award-number":["OT2CA278691"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Consensus criteria to diagnose unintentional weight loss, a condition often termed cachexia that affects most patients with advanced cancer, are based on 6-month changes by which time intervention is often ineffective. Leveraging the large and diverse population in Kaiser Permanente Northern California\u2019s community oncology practice, we studied 8338 patients with advanced lung, pancreatic, or colorectal cancers. We calculated weekly weight change measurements from 2 months pre- to 6 months post-diagnosis to identify 4 weight change trajectories (Gain, Stable, Moderate Loss, and Severe Loss) and associated these trajectories with survival. With high agreement, we classified patients into these trajectories after 3\u2009months and found them to be prognostic; those classified in Moderate (HR\u2009=\u20091.55; 95% CI = 1.45 to 1.67) or Severe Loss (HR\u2009=\u20092.20; 95% CI = 2.01 to 2.41) at 3\u2009months had significantly increased risk of death compared with the Stable trajectory. Weight loss at 3\u2009months post-diagnosis can accurately classify deleterious weight trajectories, allowing for earlier clinical intervention.<\/jats:p>","DOI":"10.1093\/jnci\/djaf030","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:03:31Z","timestamp":1739819011000},"page":"1729-1732","source":"Crossref","is-referenced-by-count":3,"title":["Early identification of weight loss trajectories in advanced cancer and associations with survival"],"prefix":"10.1093","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5682-615X","authenticated-orcid":false,"given":"Sophia","family":"Fuller","sequence":"first","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California , Pleasanton, CA 94588,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8988-6976","authenticated-orcid":false,"given":"Stacey","family":"Alexeeff","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California , Pleasanton, CA 94588,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5803-310X","authenticated-orcid":false,"given":"Bette","family":"Caan","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California , Pleasanton, CA 94588,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-9248","authenticated-orcid":false,"given":"Marcus D","family":"Goncalves","sequence":"additional","affiliation":[{"name":"Department of Medicine, NYU Langone Health , New York, NY 10016,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6608-660X","authenticated-orcid":false,"given":"Richard F","family":"Dunne","sequence":"additional","affiliation":[{"name":"Wilmot Cancer Institute, University of Rochester Medical Center , Rochester, NY 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7820-3727","authenticated-orcid":false,"given":"Tobias","family":"Janowitz","sequence":"additional","affiliation":[{"name":"Cold Spring Harbor Laboratory, Cold Spring Harbor , New York, NY 11724,","place":["United States"]},{"name":"Northwell Health Cancer Institute, Northwell Health , New Hyde Park, New York, NY 11042,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1212-1259","authenticated-orcid":false,"given":"Mariam","family":"Jamal-Hanjani","sequence":"additional","affiliation":[{"name":"Cancer Research UK Lung Cancer Centre of Excellence and Cancer Metastasis Laboratory, University College London Cancer Institute , London WC1E 6BT,","place":["United Kingdom"]},{"name":"Department of Oncology, University College London Hospitals , London WC1E 6AG,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilak K","family":"Sundaresan","sequence":"additional","affiliation":[{"name":"Department of Oncology, Kaiser Permanente San Francisco Medical Center , San Francisco, CA 94115,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-4017","authenticated-orcid":false,"given":"Elizabeth M","family":"Cespedes Feliciano","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California , Pleasanton, CA 94588,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"2026072401564541900_djaf030-B1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"2026072401564541900_djaf030-B2","doi-asserted-by":"publisher","first-page":"79884","DOI":"10.18632\/oncotarget.20168","article-title":"Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study","volume":"8","author":"Muscaritoli","year":"2017","journal-title":"Oncotarget"},{"key":"2026072401564541900_djaf030-B3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"2026072401564541900_djaf030-B4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J Clin Oncol"},{"key":"2026072401564541900_djaf030-B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.20982\/tqmp.05.1.p011","article-title":"Latent class growth modelling: a tutorial","volume":"5","author":"Andruff","year":"2009","journal-title":"TQMP"},{"key":"2026072401564541900_djaf030-B6","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00520-017-4022-z","article-title":"A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer","volume":"26","author":"Vagnildhaug","year":"2018","journal-title":"Support Care Cancer"},{"key":"2026072401564541900_djaf030-B7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00520-012-1697-z","article-title":"Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients","volume":"21","author":"Wallengren","year":"2013","journal-title":"Support Care Cancer"},{"key":"2026072401564541900_djaf030-B8","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1200\/JOP.2017.025221","article-title":"Prevalence and survival impact of pretreatment cancer-associated weight loss: a tool for guiding early palliative care","volume":"14","author":"Gannavarapu","year":"2018","journal-title":"J Oncol Pract"},{"key":"2026072401564541900_djaf030-B9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5217\/ir.2019.00076","article-title":"Nutritional issues in patients with cancer","volume":"17","author":"Kim","year":"2019","journal-title":"Intest Res"},{"key":"2026072401564541900_djaf030-B10","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","article-title":"Cachexia: a systemic consequence of progressive, unresolved disease","volume":"186","author":"Ferrer","year":"2023","journal-title":"Cell"},{"key":"2026072401564541900_djaf030-B11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/MCO.0b013e3283455d45","article-title":"Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity","volume":"14","author":"Prado","year":"2011","journal-title":"Curr Opin Clin Nutr Metabol Care"},{"key":"2026072401564541900_djaf030-B12","doi-asserted-by":"publisher","first-page":"800995","DOI":"10.3389\/fendo.2022.800995","article-title":"The relationship between diabetes mellitus and cancers and its underlying mechanisms","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026072401564541900_djaf030-B13","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.3748\/wjg.v22.i20.4794","article-title":"Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment","volume":"22","author":"Axelrad","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2026072401564541900_djaf030-B14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jaccao.2023.01.010","article-title":"Risk of cancer after diagnosis of cardiovascular disease","volume":"5","author":"Bell","year":"2023","journal-title":"JACC CardioOncol"},{"key":"2026072401564541900_djaf030-B15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1634\/theoncologist.2017-0255","article-title":"Sarcopenia is associated with quality of life and depression in patients with advanced cancer","volume":"23","author":"Nipp","year":"2018","journal-title":"Oncologist"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djaf030\/61896113\/djaf030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/117\/8\/1729\/61896113\/djaf030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/117\/8\/1729\/61896113\/djaf030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:56:56Z","timestamp":1784872616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/117\/8\/1729\/8015338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,2,18]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djaf030","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,2,18]]}}}